Maxar Gets Up To $35.8 Mln Worth Land Cover And Enhanced API Contracts From U.S. NGA

Maxar Technologies Inc. (MAXR), a space technology firm, announced Wednesday new contract awards worth up to $35.8 million from the U.S. National Geospatial-Intelligence Agency or NGA.

The first award, a one-year Period of Performance contract, is worth up to $22.5 million with $11.3 million initially funded under NGA's Janus Geography program. The company will deliver foundational geospatial intelligence data to NGA by characterizing land cover at high resolution over numerous previously unmapped areas.

Under the second contract, worth up to $13.3 million, Maxar will provide NGA's Foundation Program with a modern, enhanced application programming interface or API. It is capable of querying, discovering and downloading Maxar products derived from the company's 125-petabyte or PB high-resolution commercial imagery archive.

The API will also deliver content to the end user's cloud account rather than through legacy dissemination methods.

The enhanced API award is for a performance period of up to 4.5 years consisting of a base of six months and four full option years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines and Archer Aviation Inc. announced plans to launch the first commercial electric air taxi route in Chicago, between O'Hare International Airport or ORD and Vertiport Chicago. As part of their urban air mobility or UAM network buildout, both companies will utilize Archer's electric vertical takeoff and landing or eVTOL aircraft in the new route. Fort Wayne, Indiana-based Perfection Bakeries D/B/A Aunt Millie's is recalling 8 ct. packages of Our Family White Hot Dog Buns citing the possible presence of undeclared sesame, a known allergen, the U.S. Food and Drug Administration said. The product comes in a printed plastic package marked with "Our Family Hot Dog Buns 8 ct." on the top and has a blue twist tie. Parsippany, New Jersey -based Ascend Laboratories LLC. is recalling Dabigatran Etcxilate capsules citing the detection of N-Nitrosodimethylamine or NDMA impurity, a probable human carcinogen, the U.S. Food and Drug Administration said. The product is used as an oral anticoagulant to lower the risk of stroke and blood clots.
Follow RTT